China Universal Asset Management »

Acelyrin shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Acelyrin (SLRN) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Acelyrin

Tip: Access up to 7 years of quarterly data

All positions including Acelyrin held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelyrin by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $67k 21k 3.14
2024-09-30 $95k 19k 4.93
2024-06-30 $51k 12k 4.41
2024-03-31 $126k 19k 6.75
2023-12-31 $84k 11k 7.46

More positions owned by China Universal Asset Management

Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Meta Platforms Inc-class A Common Stock (META)
Alphabet Inc-cl A Common Stock (GOOGL)
Vertex Pharmaceuticals Common Stock (VRTX)
Gilead Sciences Common Stock (GILD)
Amgen Common Stock (AMGN)
Tesla Common Stock (TSLA)
Regeneron Pharmaceuticals Common Stock (REGN)
Netflix Common Stock (NFLX)
Taiwan Semiconductor-sp Adr (TSM)
Visa Inc-class A Shares Common Stock (V)

View all positions for China Universal Asset Management

Top funds holding Acelyrin

T. Rowe Price Investment Management
AyurMaya Capital Management Company
BlackRock
Millennium Management
Citadel Advisors
Vanguard Group
OrbiMed Advisors
venBio Partners
Tybourne Capital Management
Blue Owl Capital Holdings
General Atlantic
Samsara BioCapital
Morgan Stanley
Opaleye Management
Palo Alto Investors

View all funds holding Acelyrin